Allogene Therapeutics Company Profile

Aggregated data from the web about Allogene Therapeutics

Company Name	Allogene Therapeutics
Website	www.kitepharma.com
Snippet	Kite Pharma, a subsidiary of Gilead Sciences, develops cancer immunotherapy products with a primary focus on genetically engineered autologous T cell therapy with chimeric antigen receptors (CAR-T).
Fate	Acquired by Gilead Sciences
Type	Subsidiary
Parent	Gilead Sciences
Founded	2009
Founder	Arie Belldegrun and Joshua Kazam
Website	www.kitepharma.com
Industry	Biopharmaceutical
Products	Cancer immunotherapy
Key people	Arie Belldegrun (Chairman, President and CEO), Paul Jenkinson (CFO), David Chang (CMO)
Headquarters	Santa Monica, California
Number of employees	2,000

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.